Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Valentin who wrote (178)	3/16/1998 10:16:00 PM
From: David S.	Read Replies (1) \| Respond to of 471

lockup expiration is public info if you dig for it. also public info is Montgomery calling around to set up dog and pony shows for the company. I have assigned this stock to someone here to get more information, I would think that if jude were interested, they would have bought the company earlier for a fraction of the price. to say that a jude purchase now is counterintuitive is putting it lightly. more to come, stay tuned.

To: Valentin who wrote (178)	3/17/1998 4:47:00 PM
From: Dennis	Read Replies (1) \| Respond to of 471

Valentin, this is a quote from page 34 of MDT annual report dated 1997. We are also investigating other therapies including neurostimulation for : Parkinson's disease- stimulation of other parts of the brain (the subthalamic nucleus and the internal portion of the globu pallidus) may be effective in relieving or greatly reducing other sympotoms of Parkinson's disease, such as rigidity and akinesia. Epilepsy- our goal is to create a therapy that will detect, monitor, and treat seizures less invasively. It looks like they are in Phase I of clinical studies with Parkinson's . Nothing listed for Epilepsy which is why I think cybx would be an easy add on for MDT. Does this answer your question. Go to website www.medtronic.com to get info mailed to you.